(PDF) Erratum To: Folate Usage in MTX-treated Juvenile

Erratum To: Folate Usage in MTX-treated Juvenile Idiopathic Arthritis (JIA) Patients Is Inconsistent and Highly Variable

Rheumatology International - Germany

doi 10.1007/s00296-013-2840-y

Full Text

Abstract

Available in full text

Categories

Date

August 13, 2013

Authors

Ornella J. Rullo

Deborah K. McCurdy

Jennifer M. P. Woo

Daniel E. Furst

Publisher

Springer Science and Business Media LLC

Related search

14.4 Oligoarticular Juvenile Idiopathic Arthritis (JIA): Can Extension Be Predicted?

Pediatric Rheumatology

English

Long-Term Outcomes in Juvenile Idiopathic Arthritis: 18 Years of Follow-Up in the Population-Based Nordic Juvenile Idiopathic Arthritis (JIA) Cohort

Arthritis Care and Research

English

4.4 Different Phenotype of Anaemia in Systemic Juvenile Idiopathic Arthritis (S-Jia) Compared to Anaemia in Other Subtypes of JIA

Pediatric Rheumatology

English

165 Juvenile Idiopathic Arthritis (JIA); How Do Clinicians Define Remission and Withdraw Etanercept?

Pediatric Research

English

Time of Onset of Iridocyclitis (IC) in Children With Juvenile Idiopathic Arthritis (JIA)

Pediatric Rheumatology

English

Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Tocilizumab

Pediatric Rheumatology

English

How Do Parents of Children With Juvenile Idiopathic Arthritis (JIA) Perceive Their Therapies?

BMC Complementary and Alternative Medicine

Alternative Medicine

English

Juvenile Idiopathic Arthritis

English

Secondary Osteoporosis in Patients With Juvenile Idiopathic Arthritis

Journal of Osteoporosis

English